tiprankstipranks
Ventyx Biosciences (VTYX)
NASDAQ:VTYX
US Market

Ventyx Biosciences (VTYX) Income Statement

186 Followers

Ventyx Biosciences Income Statement

Last quarter (Q3 2023), Ventyx Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Ventyx Biosciences's net income was $-54.03M. See Ventyx Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 0.00$ 0.00
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
$ 119.08M$ -113.14M$ -67.15M$ 7.05M$ 4.18M
Operating Income
$ -196.22M$ -113.14M$ -67.15M$ -7.05M$ -4.18M
Net Non Operating Interest Income Expense
$ 16.12M$ 4.67M$ -16.55M$ -358.00K$ -146.00K
Other Income Expense
$ 1.32M$ -41.00K$ 51.00K$ -20.77M$ -1.00K
Pretax Income
$ -181.41M$ -108.43M$ -83.75M$ -28.17M$ -4.33M
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -181.42M$ -108.43M$ -85.30M$ -28.17M$ -4.33M
Basic EPS
$ -3.60$ -2.07$ -6.65$ -14.17$ -2.18
Diluted EPS
$ -3.15$ -2.07$ -6.65$ -14.17$ -2.18
Basic Average Shares
$ 227.55M$ 52.47M$ 12.83M$ 1.99M$ 1.99M
Diluted Average Shares
$ 227.55M$ 52.47M$ 12.83M$ 1.99M$ 1.99M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 119.08M$ -113.14M$ -67.15M$ 7.05M$ 4.18M
Net Income From Continuing And Discontinued Operation
$ -181.42M$ -108.43M$ -83.75M$ -28.17M$ -4.33M
Normalized Income
$ -84.74M--$ -28.17M$ -4.33M
Interest Expense
---$ 358.00K$ 146.00K
EBIT
$ -186.08M$ -108.43M$ -83.65M$ -27.82M$ -4.18M
EBITDA
$ -185.42M$ -107.98M$ -83.62M$ -27.82M$ -4.18M
Currency in USD

Ventyx Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis